Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 30

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Appropriate Total cholesterol cut-offs for detection of abnormal LDL cholesterol and non-HDL cholesterol among low cardiovascular risk population

Nantsupawat, Nopakoon, Booncharoen, Apaputch, Wisetborisut, Anawat, Jiraporncharoen, Wichuda, Pinyopornpanish, Kanokporn, Chutarattanakul, Lalita, Angkurawaranon, Chaisiri · 2019 · Lipids in Health and Disease

Abstract

BACKGROUND: Current guidelines suggest screening for dyslipidemia in early adulthood. In Thailand, a screening total cholesterol level is most commonly used potentially due to the costs of the test. However, the appropriate TC cut-off point that correlates with elevated low-density lipoprotein cholesterol (LDL-C) and non-high-density lipoprotein cholesterol (Non-HDL-C) levels for the low cardiovascular risk younger population have not been examined extensively in the literature. METHODS: This study identified 1754 subjects with low cardiovascular risk. All participants had a physical examination and a venous blood sample sent for laboratory assessment of fasting blood glucose, TC, LDL-C, HDL-C levels. A non-HDL-C level for everyone was calculated by subtracting HDL-C levels from their total cholesterol levels. Sensitivity and specificity of different TC cutoff points in detection of abnormal LDL-C levels (≥ 130 mg/dL and ≥ 160 mg/dL) and abnormal non-HDL-C levels (≥ 160 mg/dL and ≥ 190 mg/dL) were calculated. Receiver operating characteristics (ROC) curve analysis was used to evaluate the predictive utility of TC for the abnormal LDL-C and abnormal non-HDL-C levels. RESULTS: The conventional range TC cut off point, between 200 to 240, had varying diagnostic properties for detection of elevated LDL-C and Non-HDL-C within this low risk population. A TC cut off point 210 would have a sensitivity of 70% and specificity of 92.5% for detection of LDL-C ≥ 130 and a sensitivity of 96.7% and specificity of 85.6% for identifying those with Non-HDL-C ≥ 160. The TC cut off point of 230 had a sensitivity of 74.9% and specificity of 92.0% in identifying those with LDL-C ≥ 160 and a sensitivity of 98.6% and specificity of 89.8% in detection of non-HDL-C ≥ 190. CONCLUSIONS: Early screening for dyslipidemia in young adults is suggested by many guidelines. This population is likely to be those with lower cardiovascular risk and may needed to have repeated screening over time. Screening using TC with appropriate a cut off points may be a more cost-effective screening test in settings with limited resources, coverage and accessibility.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12944-019-0975-x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 24

  1. Aekplakorn W, Taneepanichskul S, Kessomboon P, Chongsuvivatwong V, Putwatana P, Sritara P, Sangwatanaroj S, Chariyalertsak S. Prevalence of dyslipidemia and Management in the Thai Population, National Health Examination Survey IV, 2009. J Lipids. 2014;2014:249584. · DOI
  2. Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, Chiuve SE, Cushman M, Delling FN, Deo R, et al. Heart disease and stroke Statistics-2018 update: a report from the American Heart Association. Circulation. 2018;137(12):e67–e492. · DOI · Paper page
  3. Gowshall M, Taylor-Robinson SD. The increasing prevalence of non-communicable diseases in low-middle income countries: the view from Malawi. Int J Gen Med. 2018;11:255–64. · DOI
  4. Bilen O, Kamal A, Virani SS. Lipoprotein abnormalities in south Asians and its association with cardiovascular disease: current state and future directions. World J Cardiol. 2016;8(3):247–57. · DOI
  5. Klag MJ, Ford DE, Mead LA, He J, Whelton PK, Liang KY, Levine DM. Serum cholesterol in young men and subsequent cardiovascular disease. N Engl J Med. 1993;328(5):313–8. · DOI · Paper page
  6. Anderson KM, Castelli WP, Levy D. Cholesterol and mortality. 30 years of follow-up from the Framingham study. JAMA. 1987;257(16):2176–80. · DOI · Paper page
  7. Corvilain B, Matte J, Litvine C. Serum cholesterol in young men and cardiovascular disease. N Engl J Med. 1993;329(2):138.
  8. Clark CJAA, Spencer RA, Pencina M, Williams K, Everson-Rose SA. Predicted long-term cardiovascular risk among young adults in the national longitudinal study of adolescent health. Am J Public Health. 2014, Dec;104(12):e108–15. · DOI · Paper page
  9. Goff DC, Jr., Lloyd-Jones DM, Bennett G, Coady S, D'Agostino RB, Sr., Gibbons R, Greenland P, Lackland DT, Levy D, O'Donnell CJ et al: 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol 2014, 63(25 Pt B):2935–2959. · DOI · Paper page
  10. Chou R, Dana T, Blazina I, Daeges M, Bougatsos C, Jeanne TL. Screening for dyslipidemia in younger adults: a systematic review for the U.S. preventive services task force. Ann Intern Med. 2016;165(8):560–4. · DOI
  11. A systematic Review to Update the 2008 U.S. Preventive services task force recommendation [ https://www.ncbi.nlm.nih.gov/books/NBK396239 /].
  12. Tangcharoensathien V, Limwattananon S, Patcharanarumol W, Thammatacharee J, Jongudomsuk P, Sirilak S. Achieving universal health coverage goals in Thailand: the vital role of strategic purchasing. Health Policy Plan. 2015;30(9):1152–61. · DOI
  13. Teerawattananon Y, Kingkaew P, Koopitakkajorn T, Youngkong S, Tritasavit N, Srisuwan P, Tantivess S. Development of a health screening package under the universal health coverage: the role of health technology assessment. Health Econ. 2016;25(Suppl Suppl 1):162–78. · DOI
  14. Chen Q-J, Lai H-M, Chen B-D, Li X-M, Zhai H, He C-H, Pan S, Luo J-Y, Gao J, Liu F, et al. Appropriate LDL-C-to-HDL-C ratio cutoffs for categorization of cardiovascular disease risk factors among Uygur adults in Xinjiang, China. Int J Environ Res Public Health. 2016;13(2):235. · DOI
  15. Zhang GM, Bai SM, Zhang GM, Ma XB, Goyal H. A novel method for estimating low-density lipoprotein (LDL) levels: Total cholesterol and non-high-density lipoprotein (HDL) can be used to predict abnormal LDL level in an apparently healthy population. Med Sci Monit. 2018;24:1688–92. · DOI
  16. Nishizawa Y, Shoji T, Kakiya R, Tsujimoto Y, Tabata T, Ishimura E, Nakatani T, Miki T, Inaba M. Non-high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease. Kidney Int Suppl. 2003;84:S117–20. · DOI
  17. Carbayo Herencia JA, Simarro Rueda M, Palazon Bru A, Molina Escribano F, Ponce Garcia I, Artigao Rodenas LM, Caldevilla Bernardo D, Divison Garrote JA, Gil Guillen VF, Todos en nombre del Grupo de Enfermedades Vasculares de a: Evaluation of non-HDL cholesterol as a predictor of non-fatal cardiovascular events in a prospective population cohort. Clin Investig Arterioscler 2018, 30(2):64–71. · DOI
  18. Angkurawaranon C, Wisetborisut A, Jiraporncharoen W, Likhitsathian S, Uaphanthasath R, Gomutbutra P, Jiraniramai S, Lerssrimonkol C, Aramrattanna A, Doyle P, et al. Chiang Mai University health worker study aiming toward a better understanding of noncommunicable disease development in Thailand: methods and description of study population. Clinical Epidemiology. 2014;6:277–86. · DOI
  19. World Health Organization. The WHO STEPwise approach to noncommunicable disease risk factor surveillance (STEPS). In: WHO STEPS surveillance manual; 2017.
  20. Executive Summary of The Third Report of The National Cholesterol Education Program. (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). Jama. 2001;285(19):2486–97. · DOI · Paper page
  21. Veghari G, Sedaghat M, Joshghani H, Niknezad F, Angizeh A, Tazik E, Moharloei P, Banihashem S. Plasma total cholesterol level and some related factors in northern Iranian people. J Nat Sci Biol Med. 2013;4(2):359–63. · DOI
  22. Costa J, Borges M, Oliveira E, Gouveia M, Carneiro AV. Incidence and prevalence of hypercholesterolemia in Portugal: a systematic review Part III. Rev Port Cardiol. 2003;22(6):829–36.
  23. Jeong SM, Choi S, Kim K, Kim SM, Lee G, Park SY, Kim YY, Son JS, Yun JM, Park SM. Effect of change in Total cholesterol levels on cardiovascular disease among young adults. J Am Heart Assoc. 2018;7(12):1–17. · DOI · Paper page
  24. Scicchitano P, Cameli M, Maiello M, Modesti PA, Muiesan ML, Novo S, Palmiero P, Saba PS, Pedrinelli R, Ciccone MM. Nutraceuticals and dyslipidaemia: beyond the common therapeutics. J Funct Foods. 2014;6:11–32. · DOI · Paper page

Metadata

Authors
Nantsupawat, N., Booncharoen, A., Wisetborisut, A., Jiraporncharoen, W., Pinyopornpanish, K., Chutarattanakul, L., & Angkurawaranon, C.
Venue
Lipids in Health and Disease
Published
2019-01-26
Volume
18
Issue
1
ISSN
1476-511X
Cited by
30
References
4
Language
en
Licence
creativecommons.org/licenses/by/4.0/ (tdm)
Funders
Faculty of Medicine Research Fund, Chiang Mai University, Chiang Mai, Thailand.

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Appropriate Total cholesterol cut-offs for detection of abnormal LDL cholesterol and non-HDL cholesterol among low cardiovascular risk population. https://app.cochat.ai/papers/10.1186/s12944-019-0975-x
The paper
Nantsupawat, N., Booncharoen, A., Wisetborisut, A., Jiraporncharoen, W., Pinyopornpanish, K., Chutarattanakul, L., & Angkurawaranon, C. (2019). Appropriate Total cholesterol cut-offs for detection of abnormal LDL cholesterol and non-HDL cholesterol among low cardiovascular risk population. Lipids in Health and Disease. https://doi.org/10.1186/s12944-019-0975-x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.